Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin. 2012

Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
Animal Biotechnology, Graduate School of Bio & Information Technology, Institute of Genetic Engineering, Hankyong National University, Ansung 456-749, Korea.

BACKGROUND Dimeric human erythropoietin (dHuEPO) peptides are reported to exhibit significantly higher biological activity than the monomeric form of recombinant EPO. The objective of this study was to produce transgenic (tg) mice expressing dHuEPO and to investigate the characteristics of these mice. METHODS A dHuEPO-expressing vector under the control of the goat beta-casein promoter, which produced a dimer of human EPO molecules linked by a 2-amino acid peptide linker (Asp-Ile), was constructed and injected into 1-cell fertilized embryos by microinjection. Mice were screened using genomic DNA samples obtained from tail biopsies. Blood samples were obtained by heart puncture using heparinized tubes, and hematologic parameters were assessed. Using the microarray analysis tool, we analyzed differences in gene expression in the spleens of tg and control mice. RESULTS A high rate of spontaneous abortion or death of the offspring was observed in the recipients of dHuEPO embryos. We obtained 3 founder lines (#4, #11, and #47) of tg mice expressing the dHuEPO gene. However, only one founder line showed stable germline integration and transmission, subsequently establishing the only transgenic line (#11). We obtained 2 F1 mice and 3 F2 mice from line #11. The dHuEPO protein could not be obtained because of repeated spontaneous abortions in the tg mice. Tg mice exhibited symptoms such as short lifespan and abnormal blood composition. The red blood cell count, white blood cell count, and hematocrit levels in the tg mice were remarkably higher than those in the control mice. The spleens of the tg mice (F1 and F2 females) were 11- and -21-fold larger than those of the control mice. Microarray analysis revealed 2,672 spleen-derived candidate genes; more genes were downregulated than upregulated (849/764). Reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative real-time PCR (qRT-PCR) were used for validating the results of the microarray analysis of mRNA expression. CONCLUSIONS In conclusion, dHuEPO tg mice caused excessive erythrocytosis that led to abnormal blood composition, short lifespan, and abnormal splenomegaly. Further, we identified 2,672 genes associated with splenomegaly by microarray analysis. These results could be useful in the development of dHuEPO-producing tg animals.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011086 Polycythemia An increase in the total red cell mass of the blood. (Dorland, 27th ed) Erythrocytosis,Erythrocytoses,Polycythemias
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011250 Pregnancy Complications, Hematologic The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Complications, Hematologic Pregnancy,Hematologic Pregnancy Complications,Pregnancy Complications, Hematological,Pregnancy, Hematologic Complications,Complication, Hematologic Pregnancy,Complication, Hematological Pregnancy,Complications, Hematological Pregnancy,Hematologic Pregnancy Complication,Hematological Pregnancy Complication,Hematological Pregnancy Complications,Pregnancies, Hematologic Complications,Pregnancy Complication, Hematologic,Pregnancy Complication, Hematological
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D000034 Abortion, Veterinary Premature expulsion of the FETUS in animals. Veterinary Abortion,Abortions, Veterinary,Veterinary Abortions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
April 1989, Proceedings of the National Academy of Sciences of the United States of America,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
July 1994, Endocrinology,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
November 1996, The Journal of biological chemistry,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
June 2002, Journal of the National Cancer Institute,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
February 1997, Gene,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
October 1991, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
May 1998, Investigative ophthalmology & visual science,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
April 1994, Current opinion in lipidology,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
April 1994, Annals of the New York Academy of Sciences,
Seong-Jo Yun, and Purevjargal Naidansuren, and Bo-Woong Sim, and Jong-Ju Park, and Cha-Won Park, and Tseeleema Nanjidsuren, and Myung-Hwa Kang, and Sue-Yun Hwang, and Jong-Taek Yoon, and Kwan-Sik Min
January 2004, Blood cells, molecules & diseases,
Copied contents to your clipboard!